Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-20

Clinical Trial Update: Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients [Phase 4]

View source ↗

Summary

A Phase 4 study assessed how body weight affects the efficacy of metformin (Glucophage) in Chinese patients diagnosed with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucophage (metformin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2013-08-20